The CD44 role in human cancer metastasis (and a possible therapeutic effect) was studied in several cancer cells, but CD44 gene single-nucleotide polymorphism (SNP) and its role in HCC development and clinical features remain poorly investigated [13,14,15,16,17]. This evidence concerns the gene CD44 and cancer.